Connect with us

Technology

Quantum Computing Boom: $1 Trillion in Value Creation Forecasted by 2035

Published

on

Issued on behalf of Scope Technologies Corp. with the installation of new hardware.

VANCOUVER, BC, Dec. 5, 2024 /PRNewswire/ — USA News Group News Commentary – In recent weeks, Amazon’s quantum advancements have ignited significant momentum across the market, propelling the industry closer to the dawn of the “Quantum Age.” In response, the U.S. government has acted decisively, partnering with quantum pioneers to support a $2.7 billion National Quantum Initiative Reauthorization Act. While Polaris Market Research previously estimated the Global Quantum Computing Market could exceed US$5.7 billion by 2032 at an impressive 19.1% CAGR, updated projections from The Quantum Insider now anticipate quantum computing could generate $1 trillion in value by 2035. At the forefront of this technological revolution are companies driving advancements in quantum computing and infrastructure, including Scope Technologies Corp. (CSE: SCPE) (OTCQB: SCPCF), Quantum Computing Inc. (QCi) (NASDAQ: QUBT), Cisco Systems, Inc. (NASDAQ: CSCO), Rigetti Computing, Inc. (NASDAQ: RGTI, RGTIW), and International Business Machines Corporation (IBM) (NYSE: IBM).

The article continued: Analysts at IDTechEx predict even stronger growth for the Global Quantum Computing Market, forecasting a 30% CAGR through 2045. As industries prepare for this transition, the World Economic Forum has emphasized public-private collaborations within the financial sector to strengthen security for the post-quantum era.

Scope Technologies Expands Global Entropy Delivery Network with Significant Data-in-Transit Security Advancements

Scope Technologies Corp. (CSE: SCPE) (OTCQB: SCPCF), a pioneering technology company specializing in quantum security and machine learning (ML), today announced significant advancements to its data-in-transit security infrastructure with the installation of new hardware. These updates, which expand Scope’s entropy delivery system across new locations in Europe, Asia, and North America, represent a milestone in delivering secure and efficient global data transmission.

The expanded network enhances the speed and redundancy of QSE’s services while significantly reducing latency for businesses worldwide. These improvements not only ensure faster, more reliable data encryption but also strengthen protections against cyber threats such as man-in-the-middle attacks and Harvest Now, Decrypt Later (HNDL) strategies.

“Our global network expansion reflects our commitment to providing unparalleled data security,” said Sean Prescott, Founder and CTO of QSE Group. “By increasing our infrastructure’s speed and reliability, we’re not only enhancing the user experience but also building the resilience needed to safeguard data during transmission, now and into the future. This is critical for industries handling sensitive information, where interception risks can lead to significant consequences.”

As part of Scope’s mission to continuously advance quantum-resilient encryption, these updates position the QSE platform as a leader in secure, real-time communications. The advancements also align with industry compliance requirements, offering organizations a seamless, secure solution to meet regulatory demands.

Moreover, these upgrades lay the groundwork for QSE’s forthcoming secure mobile application, designed to provide industries with rapid, encrypted data-sharing capabilities. Further announcements on this next-generation platform are expected soon.

Scope Technologies’ commitment to expanding its infrastructure ensures that businesses and individuals are equipped with the tools needed to protect their data against current and emerging threats.

The announcement follows Scope’s recent announcement of the signing of a Letter of Intent (LOI) with Global Care Innovations Inc. (GCI) and BitLab. This strategic partnership aims to provide quantum-secure data solutions and advanced AI-powered tools to healthcare providers throughout North America.

As well, Scope recently launched a subscription model offering round-trip encrypted, quantum-resilient cloud storage for both businesses and individuals. With this new strategic partnership, Scope aims to demonstrate its capability to improve patient care through advanced technology and solidify its position as a leader in secure technology solutions for critical sectors such as healthcare.

CONTINUED… Read this and more news for Scope AI at:  https://usanewsgroup.com/2024/04/26/the-currency-of-tomorrow-why-investing-in-cutting-edge-ai-recognition-tech-could-mean-big-money/

In other industry developments and happenings in the market include:

Quantum Computing Inc. (QCi) (NASDAQ: QUBT), an innovative, integrated photonics and quantum optics technology company, recently announced it received its second purchase order for its thin film lithium niobate (TFLN) photonic chip foundry from the University of Texas at Austin. The order will support the research efforts of the University’s RF Acoustic Microsystem Group and is part of the QCi Foundry’s pilot launch program, with fulfillment expected in Q1 2025. 

The order enables the University to advance chip-scale acoustic and cross-domain microsystems using QCi Foundry’s scalable TFLN processes, supporting a custom fabrication run that highlights TFLN’s versatility for next-generation photonics and micro electromechanical systems.

“This strategic collaboration with the University of Texas at Austin underscores the expanding capabilities and commercial viability of the QCi Foundry, which has been designed to meet the increasing demand for signal processing, sensing, and computing applications as well as advanced acoustic systems for volume deployment,” said Dr. William McGann, CEO at QCi. “We are excited to support the University’s innovative research, and this collaboration further highlights the growing recognition of TFLN as a critical driver in the future of telecom, datacom, and quantum markets.”

Cisco Systems, Inc. (NASDAQ: CSCO), a tech infrastructure giant, recently announced at its Quantum Summit 2024 that Cisco researchers are reporting substantial efforts are underway now to develop practical quantum networks and data centers. Cisco’s vision for a quantum data center includes the ability to execute multiple quantum circuits, support dynamic network interconnections, and leverage diverse entanglement generation protocols, according to Reza Nejabati, head of quantum research at Cisco’s advanced development group Outshift, during a presentation at the event.

“It is well known in academic research that quantum computing cannot become useful by monolithically scaling it to 10s of millions of qubits—that is not practical,” said Nejabati. “It seems, at least with the current technology, it is more realistic to build a network of smaller quantum computers. And essentially you develop the notion of the data center—that is we build a network connecting a large number of smaller processors in a controlled environment, the data center warehouse, and provide them as a service to a larger user base. That’s the basic definition of a quantum data center.”

Rigetti Computing, Inc. (NASDAQ: RGTI, RGTIW), a pioneer in full-stack quantum-classical computing, recently announced that it successfully completed sales of $100 million gross proceeds of its common equity offering program. Rigetti immediately followed up by announcing another $100 million registered direct offering, while intending to use the funds generated by the previous fund raising for working capital, capital expenditures and other general corporate purposes, including continuing to focus on its strategy as a leader in superconducting quantum computing and continuing to work to improve its 2-qubit gate fidelity and scale towards higher qubit count systems.

“We are pleased to see the enthusiasm for the quantum computing sector and our company,” said Dr. Subodh Kulkarni, CEO of Rigetti. “We are seeing a great deal of interest from national labs and academic institutions for on-premises quantum computers to pursue hands-on R&D. As the technology continues to improve and more quantum applications are developed we expect to see increasingly more interest from industry and the private sector.”

International Business Machines Corporation (IBM) (NYSE: IBM), a computing giant that provides integrated solutions and services worldwide, recently announced quantum hardware and software advancements to execute complex algorithms on IBM quantum computers with record levels of scale, speed, and accuracy.

IBM Quantum Heron, the company’s most advanced quantum processor, can now run certain quantum circuits with up to 5,000 two-qubit gates, nearly doubling its previous capability and completing tasks 50 times faster than last year’s demonstration. Combined with IBM’s enhanced Qiskit software, which leads the industry in performance and reliability, these advancements push the boundaries of quantum computing’s potential in tackling complex scientific challenges.

“Advances across our hardware and Qiskit are enabling our users to build new algorithms in which advanced quantum and classical supercomputing resources can be knit together to combine their respective strengths,” said Jay Gambetta, Vice President, IBM Quantum. “As we advance on our roadmap towards error-corrected quantum systems, the algorithms discovered today across industries will be key to realizing the potential to solve new problems realized through the convergence of QPUs, CPUs, and GPUs.”

Article Source: https://usanewsgroup.com/2024/04/26/the-currency-of-tomorrow-why-investing-in-cutting-edge-ai-recognition-tech-could-mean-big-money/ 

CONTACT:
USA NEWS GROUP
info@usanewsgroup.com
(604) 265-2873

DISCLAIMER: Nothing in this publication should be considered as personalized financial advice. We are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed financial advisor before making any investment decision. This is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. USA News Group is a wholly-owned subsidiary of Market IQ Media Group, Inc. (“MIQ”). MIQ has been paid a fee for Scope Technologies Corp. advertising and digital media from the company directly. There may be 3rd parties who may have shares Scope Technologies Corp., and may liquidate their shares which could have a negative effect on the price of the stock. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. Because of this conflict, individuals are strongly encouraged to not use this publication as the basis for any investment decision. The owner/operator of MIQ own shares of Scope Technologies Corp. which were purchased as a part of a private placement. MIQ reserves the right to buy and sell, and will buy and sell shares of Scope Technologies Corp. at any time thereafter without any further notice. We also expect further compensation as an ongoing digital media effort to increase visibility for the company, no further notice will be given, but let this disclaimer serve as notice that all material disseminated by MIQ has been approved by the above mentioned company; this is a paid advertisement, and we own shares of the mentioned company that we will sell, and we also reserve the right to buy shares of the company in the open market, or through further private placements and/or investment vehicles. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between any predictions and actual results. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.

View original content:https://www.prnewswire.co.uk/news-releases/quantum-computing-boom-1-trillion-in-value-creation-forecasted-by-2035-302323917.html

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Baidu to Report First Quarter 2026 Financial Results on May 18, 2026

Published

on

By

BEIJING, April 23, 2026 /PRNewswire/ — Baidu, Inc. (Nasdaq: BIDU; HKEX: 9888 (HKD Counter) and 89888 (RMB Counter)) (“Baidu” or the “Company”), a leading AI company with strong Internet foundation, today announced that it will report its financial results for the First Quarter 2026 ended March 31, 2026, before the U.S. market opens on May 18, 2026. Baidu’s management will hold an earnings conference call at 8:00 AM on May 18, 2026, U.S. Eastern Time (8:00 PM on May 18, 2026, Beijing Time).

Please register in advance of the conference call using the link provided below. It will automatically direct you to the registration page of “Baidu Inc. Q1 2026 Earnings Conference Call”. Please follow the steps to enter your registration details, then click “Register”. Upon registering, you will then be provided with the dial-in number, the passcode, and your unique access PIN. This information will also be emailed to you as a calendar invite.

For pre-registration, please click:
https://s1.c-conf.com/diamondpass/10054331-iu876y.html

In the 10 minutes prior to the call start time, you may use the conference access information (including dial-in number(s), the passcode and unique access PIN) provided in the calendar invite that you have received following your pre-registration.

Additionally, a live and archived webcast of this conference call will be available at https://ir.baidu.com.

A replay of the conference call may be accessed by phone at the following number until May 25, 2026:
US: 1 855 883 1031
Reply PIN: 10054331

About Baidu

Founded in 2000, Baidu’s mission is to make the complicated world simpler through technology. Baidu is a leading AI company with strong Internet foundation, trading on Nasdaq under “BIDU” and the HKEX under “9888.” One Baidu ADS represents eight Class A ordinary shares.

View original content:https://www.prnewswire.com/news-releases/baidu-to-report-first-quarter-2026-financial-results-on-may-18-2026-302751204.html

SOURCE Baidu, Inc.

Continue Reading

Technology

Phase 1 of 139th Canton Fair Introduces New Dedicated Product Zones as Emerging Technologies Take Center Stage

Published

on

By

GUANGZHOU, China, April 23, 2026 /PRNewswire/ — The 139th China Import and Export Fair (Canton Fair) has further optimized its exhibition landscape with nine new dedicated product zones, reflecting ongoing structural shifts in global trade and the continued upgrading of China’s export portfolio.

Among the most closely watched additions in Phase 1 are the consumer and agricultural drone zones, both making their debut at the Canton Fair and offering a focused showcase of applications in the low‑altitude economy. The consumer drone zone showcases progress in flight control, AI‑based obstacle avoidance and energy efficiency across imaging, tourism, emergency response and patrol. The agricultural drone zone highlights precision farming, with spraying, seeding and field‑management demonstrations showing terrain‑following, intelligent route planning, and precise payload control.

On day one, a Shandong‑based drone manufacturer welcomed buyers from 30+ countries, with over 50 strong leads. One buyer, after seeing load and wind‑resistance demonstrations, immediately confirmed three sample units and even proposed becoming a regional distributor.

Display technology is another focal point of Phase 1, highlighting advances in color accuracy, energy efficiency, and overall visual performance. Developments in fine‑grained control, expanded color gamut, and reduced power consumption point to a clear trend toward immersive viewing experiences combined with sustainability gains.

The smart wearables zone underscores how intelligent devices are becoming key interfaces for human‑machine interaction. From real‑time language translation and adaptive noise cancellation to long‑term health monitoring and AI‑enabled eyewear, wearables are evolving from standalone products into integrated systems that support communication, well‑being, and productivity across daily and professional settings.

The service robots zone further illustrates how artificial intelligence is moving from conceptual exploration to large‑scale deployment. Advanced robots showcased across industrial, commercial, medical, and public‑service scenarios demonstrate growing autonomy, multi‑sensory perception, and closer human-robot collaboration.

By bringing emerging technologies into clearer focus through dedicated zones, the 139th Canton Fair is reinforcing its function as a platform where trade trends take shape, innovation meets application, and global buyers gain early insights into cutting-edge technologies.

For pre-registration, please click: https://buyer.cantonfair.org.cn/register/buyer/email?source_type=16

Photo – https://mma.prnewswire.com/media/2963958/1.jpg

View original content:https://www.prnewswire.co.uk/news-releases/phase-1-of-139th-canton-fair-introduces-new-dedicated-product-zones-as-emerging-technologies-take-center-stage-302751520.html

Continue Reading

Technology

OZMOSI Announces Strategic Partnership with Planview to Advance AI-Driven Planning in Pharmaceutical R&D

Published

on

By

By combining structured clinical intelligence with AI-driven portfolio planning, the partnership gives pharmaceutical teams a faster, clearer way to make high-stakes R&D decisions

SPRING LAKE HEIGHTS, N.J., April 23, 2026 /PRNewswire/ — OZMOSI, a leading provider of structured pharmaceutical development intelligence, today announced a strategic partnership with Planview, the leading AI-powered end-to-end platform for Strategic Portfolio Management (SPM) and Digital Product Delivery (DPD).

By integrating OZMOSI’s machine-readable clinical datasets directly into Planview’s AI-driven portfolio planning platform, external scientific data is now connected to internal R&D planning in one system,  helping pharmaceutical organizations better predict market shifts, prioritize R&D investments, and make faster, more confident decisions.

This integration brings external clinical reality into internal R&D decision-making, so teams can plan based on what’s actually happening, not just on what they hope will happen.

The two organizations combine deep expertise in complementary areas, united by a shared focus on improving the quality and usability of data for strategic decision-making. OZMOSI provides structured, machine-readable intelligence across clinical trials, drug development programs, regulatory activity, and scientific literature, built on a consistent taxonomy that standardizes how data is connected and understood. Planview’s platform enables organizations to model complex investment scenarios, align initiatives with corporate strategy, and optimize resource allocation.

Together, these capabilities give teams a clearer, more complete view of the R&D landscape, grounded in clean, standardized data and strengthened by AI-driven analysis.

“AI is only as powerful as the data that fuels it,” said Beau Bush, President and Founder of OZMOSI. “Pharmaceutical organizations have no shortage of data, but too often it’s fragmented, inconsistent, and difficult to operationalize. By bringing OZMOSI’s structured data foundation together with Planview’s AI-driven planning capabilities, we’re enabling teams to move beyond disconnected analysis and toward truly integrated, forward-looking decision-making.”

“Strategic planning in pharmaceutical R&D is becoming increasingly dependent on advanced analytics and AI,” said  Louise Allen, Chief Product Officer at Planview. “Integrating OZMOSI’s clinical intelligence into Planview’s platform enables pharmaceutical leaders to make better decisions by combining trusted external data with AI-driven planning

OZMOSI’s dataset spans more than 800,000 clinical trials, over 35,000 drugs, and 4,000 diseases and conditions. It brings together insights from clinical trial registries, regulatory filings, scientific literature, company disclosures, and industry announcements into a unified, structured dataset.

When integrated into Planview’s platform, this intelligence enables pharmaceutical and biotech organizations to evaluate competitive landscapes, identify emerging clinical trends, and simulate portfolio outcomes with unprecedented precision.

Together, OZMOSI and Planview are redefining how pharmaceutical organizations approach R&D strategy, ensuring that investment decisions are guided by accurate, standardized, and AI-ready data. By combining internal portfolio visibility with a continuously updated external view of the market, the partnership helps leaders not only understand what they have, but what to do next.

About OZMOSI

Founded in 2013, OZMOSI specializes in transforming complex pharmaceutical R&D intelligence into structured, machine-readable data. The company provides the foundation needed for accurate competitive analysis, product forecasting, and portfolio strategy. Through its proprietary taxonomy and semantic layer, OZMOSI connects fragmented data across the pharmaceutical ecosystem, enabling faster, more confident decision-making for global pharma, biotech, and investment teams.

Based in Spring Lake Heights, New Jersey, OZMOSI is focused on making pharmaceutical intelligence clear, usable, and ready for the future of AI-driven strategy. Learn more at www.ozmosi.com.

About Planview

Planview is the leading end-to-end platform for Strategic Portfolio Management (SPM) and Digital Product Delivery (DPD), powered by advanced AI capabilities that give business and technology leaders the strategic foresight to prioritize investments and initiatives, make plans real within constraints, and pivot with certainty when things change. Our AI-driven connected platform of solutions underpins the business and digital transformations of more than 3,000 customers and 3.1 million users globally. Headquartered in Austin, Texas, Planview has over 1,500 employees worldwide. Learn more at www.planview.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/ozmosi-announces-strategic-partnership-with-planview-to-advance-ai-driven-planning-in-pharmaceutical-rd-302750944.html

SOURCE Ozmosi Company

Continue Reading

Trending